217 related articles for article (PubMed ID: 19112016)
41. [Establishment of human neuroectodermal tumor cell line (PFSK) with stable expression of xanthine oxidoreductase].
Liu X; Liu L; Yan XH; Xu P
Shi Yan Sheng Wu Xue Bao; 2001 Sep; 34(3):247-52. PubMed ID: 12549228
[TBL] [Abstract][Full Text] [Related]
42. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex.
Notarnicola M; Altomare DF; Calvani M; Orlando A; Bifulco M; D'Attoma B; Caruso MG
Oncology; 2006; 71(5-6):327-32. PubMed ID: 17687193
[TBL] [Abstract][Full Text] [Related]
43. Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies.
Silverman AL; Bronstein JC; Krymgold S; Kahlon D; Bull AW
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):53-6. PubMed ID: 8770467
[TBL] [Abstract][Full Text] [Related]
44. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer.
Hibi K; Goto T; Mizukami H; Kitamura YH; Sakuraba K; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Jun; 29(6):2215-7. PubMed ID: 19528483
[TBL] [Abstract][Full Text] [Related]
45. [Prognostic significance of clinical and pathomorphological factors in colorectal cancer: a uni- and multivariate analysis].
Szynglarewicz B; Grzebieniak Z; Forgacz J; Pudełko M; Rapała M
Pol Merkur Lekarski; 2004 Dec; 17(102):586-9. PubMed ID: 15771128
[TBL] [Abstract][Full Text] [Related]
46. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
[TBL] [Abstract][Full Text] [Related]
47. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
Gassler N; Herr I; Schneider A; Penzel R; Langbein L; Schirmacher P; Kopitz J
J Pathol; 2005 Nov; 207(3):295-300. PubMed ID: 16110457
[TBL] [Abstract][Full Text] [Related]
48. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
49. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
[TBL] [Abstract][Full Text] [Related]
50. Xanthine oxidoreductase activity in human liver disease.
Stirpe F; Ravaioli M; Battelli MG; Musiani S; Grazi GL
Am J Gastroenterol; 2002 Aug; 97(8):2079-85. PubMed ID: 12190180
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of growth differentiation factor 11 in colorectal cancer.
Yokoe T; Ohmachi T; Inoue H; Mimori K; Tanaka F; Kusunoki M; Mori M
Int J Oncol; 2007 Nov; 31(5):1097-101. PubMed ID: 17912435
[TBL] [Abstract][Full Text] [Related]
52. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.
Li W; Yu CP; Xia JT; Zhang L; Weng GX; Zheng HQ; Kong QL; Hu LJ; Zeng MS; Zeng YX; Li M; Li J; Song LB
Clin Cancer Res; 2009 Feb; 15(4):1393-9. PubMed ID: 19228740
[TBL] [Abstract][Full Text] [Related]
53. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
54. p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours.
Paluszkiewicz P; Berbeć H; Pawłowska-Wakowicz B; Cybulski M; Paszkowska A
Cancer Detect Prev; 2004; 28(4):252-9. PubMed ID: 15350628
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
56. Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa.
Kummola L; Hämäläinen JM; Kivelä J; Kivelä AJ; Saarnio J; Karttunen T; Parkkila S
BMC Cancer; 2005 Apr; 5():41. PubMed ID: 15836783
[TBL] [Abstract][Full Text] [Related]
57. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
Bautista CV; Felis CP; Espinet JM; García JB; Salas JV
Dis Colon Rectum; 2007 May; 50(5):611-20. PubMed ID: 17297554
[TBL] [Abstract][Full Text] [Related]
58. Progressive loss of perivascular nerves adjacent to colorectal cancer.
Chamary VL; Robson T; Loizidou M; Boulos PB; Burnstock G
Eur J Surg Oncol; 2000 Sep; 26(6):588-93. PubMed ID: 11034811
[TBL] [Abstract][Full Text] [Related]
59. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
60. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
